Tapewire

Nasdaq · USD

ALNY

ALNYLAM PHARMACEUTICALS, INC.

Export transactions ↓
Tapewire entity
3132
SEC CIK
0001178670
Parsed reports
483

Last 12 months

Inside the activity.

0 purchase rows · 279 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025031
Dec 202500
Jan 20260111
Feb 2026011
Mar 20260106
Apr 2026014
May 202600
Jun 202605
Jul 202600
Aug 202600
Sep 202600
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 15, 2024 Filed Feb 20, 2024 21:07 UTC
Greenstreet YvonneDirector · Chief Executive Officer
GrantCommon Stock 16,953 $0.00 $0.00
Disclosure

SEC source: 0001735276-24-000007 · edgardoc.xml · nonDerivative · entry 1

Greenstreet Yvonne · CIK 0001446125 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,169

F1 · kind: On February 23, 2022, the reporting person was granted a performance-based stock unit (PSU) under the 2018 Stock Incentive Plan. The shares subject to the PSU vest based on the achievement of three specified performance measures. The shares reported were issued to the reporting person upon vesting of one-third of the shares subject to the PSU based on the issuer publicly reporting $1.5 billion in total annual revenue, as determined by The People, Culture and Compensation Committee of the Issuer Board of Directors on February 15, 2024.

Read SEC document
February 02, 2024 Filed Feb 5, 2024 21:05 UTC
Franchini Indrani LallEVP, CLO & Secretary
SaleCommon Stock 269 $172.38 $46,370.22
Disclosure

SEC source: 0001735276-24-000002 · edgardoc.xml · nonDerivative · entry 4

Franchini Indrani Lall · CIK 0001708764 · EVP, CLO & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,584

F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form.

F4 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $171.80 to $172.60. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
February 02, 2024 Filed Feb 5, 2024 21:05 UTC
Franchini Indrani LallEVP, CLO & Secretary
SaleCommon Stock 820 $171.14 $140,334.80
Disclosure

SEC source: 0001735276-24-000002 · edgardoc.xml · nonDerivative · entry 3

Franchini Indrani Lall · CIK 0001708764 · EVP, CLO & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,853

F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form.

F3 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $170.58 to $171.54. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
February 02, 2024 Filed Feb 5, 2024 21:05 UTC
Franchini Indrani LallEVP, CLO & Secretary
SaleCommon Stock 502 $170.01 $85,345.02
Disclosure

SEC source: 0001735276-24-000002 · edgardoc.xml · nonDerivative · entry 2

Franchini Indrani Lall · CIK 0001708764 · EVP, CLO & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,673

F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form.

F2 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $169.57 to $170.57. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
February 01, 2024 Filed Feb 5, 2024 21:05 UTC
Franchini Indrani LallEVP, CLO & Secretary
Exercise / conversionRestricted Stock Units · Derivative 5,175 $0.00 $0.00
Disclosure

SEC source: 0001735276-24-000002 · edgardoc.xml · derivative · entry 5

Franchini Indrani Lall · CIK 0001708764 · EVP, CLO & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,175

Underlying: Common Stock · 5,175 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ALNY common stock.

F6 · derivative.exercise_date: On February 1, 2022 the reporting person received 15,525 restricted stock units that vest ratably on each of the first, second and third anniversaries of the Grant Date. On February 1, 2024, the second tranche of restricted stock units from the February 1, 2022 grant vested and was released, as reported on this Form 4.

F6 · derivative.expiration_date: On February 1, 2022 the reporting person received 15,525 restricted stock units that vest ratably on each of the first, second and third anniversaries of the Grant Date. On February 1, 2024, the second tranche of restricted stock units from the February 1, 2022 grant vested and was released, as reported on this Form 4.

Read SEC document
February 01, 2024 Filed Feb 5, 2024 21:05 UTC
Franchini Indrani LallEVP, CLO & Secretary
Exercise / conversionCommon Stock 5,175 $0.00 $0.00
Disclosure

SEC source: 0001735276-24-000002 · edgardoc.xml · nonDerivative · entry 1

Franchini Indrani Lall · CIK 0001708764 · EVP, CLO & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,175

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 27, 2023 Filed Dec 29, 2023 21:03 UTC Exercise / conversionStock Option (right to buy) · Derivative 30,000 $0.00 Strike: $96.45 $0.00
Disclosure

SEC source: 0001735276-23-000081 · edgardoc.xml · derivative · entry 4

BONNEY MICHAEL W · CIK 0001219016 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 30,000 shares

Expires 2024-12-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2023.

F3 · derivative.exercise_date: The stock option was fully vested as of 12/17/2017.

Read SEC document
December 27, 2023 Filed Dec 29, 2023 21:03 UTC SaleCommon Stock 30,000 $195.00 $5,850,000.00
Disclosure

SEC source: 0001735276-23-000081 · edgardoc.xml · nonDerivative · entry 2

BONNEY MICHAEL W · CIK 0001219016 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,029

F1 · kind: The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2023.

Read SEC document
December 27, 2023 Filed Dec 29, 2023 21:03 UTC Exercise / conversionCommon Stock 30,000 $96.45 $2,893,500.00
Disclosure

SEC source: 0001735276-23-000081 · edgardoc.xml · nonDerivative · entry 1

BONNEY MICHAEL W · CIK 0001219016 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 46,029

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2023.

Read SEC document
August 07, 2023 Filed Aug 7, 2023 22:05 UTC
Garg PushkalCMO & EVP Dev & Med Affairs
SaleCommon Stock 240 $185.32 $44,476.80
Disclosure

SEC source: 0001735276-23-000079 · edgardoc.xml · nonDerivative · entry 11

Garg Pushkal · CIK 0001829252 · CMO & EVP Dev & Med Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,345

F9 · kind: These sales were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2022.

F12 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $185.20 to $185.61. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
August 07, 2023 Filed Aug 7, 2023 22:05 UTC
Garg PushkalCMO & EVP Dev & Med Affairs
SaleCommon Stock 814 $184.65 $150,305.10
Disclosure

SEC source: 0001735276-23-000079 · edgardoc.xml · nonDerivative · entry 10

Garg Pushkal · CIK 0001829252 · CMO & EVP Dev & Med Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,585

F9 · kind: These sales were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2022.

F11 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $184.12 to $184.89. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
August 07, 2023 Filed Aug 7, 2023 22:05 UTC
Garg PushkalCMO & EVP Dev & Med Affairs
SaleCommon Stock 3,112 $183.58 $571,300.96
Disclosure

SEC source: 0001735276-23-000079 · edgardoc.xml · nonDerivative · entry 9

Garg Pushkal · CIK 0001829252 · CMO & EVP Dev & Med Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,399

F9 · kind: These sales were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2022.

F10 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $183.09 to $184.05. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
August 04, 2023 Filed Aug 7, 2023 22:05 UTC
Garg PushkalCMO & EVP Dev & Med Affairs
SaleCommon Stock 164 $189.31 $31,046.84
Disclosure

SEC source: 0001735276-23-000079 · edgardoc.xml · nonDerivative · entry 8

Garg Pushkal · CIK 0001829252 · CMO & EVP Dev & Med Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,511

F3 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form.

Read SEC document
August 04, 2023 Filed Aug 7, 2023 22:05 UTC
Garg PushkalCMO & EVP Dev & Med Affairs
SaleCommon Stock 15 $188.40 $2,826.00
Disclosure

SEC source: 0001735276-23-000079 · edgardoc.xml · nonDerivative · entry 7

Garg Pushkal · CIK 0001829252 · CMO & EVP Dev & Med Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,675

F3 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form.

F8 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $188.14 to $189.05. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
August 04, 2023 Filed Aug 7, 2023 22:05 UTC
Garg PushkalCMO & EVP Dev & Med Affairs
SaleCommon Stock 86 $187.37 $16,113.82
Disclosure

SEC source: 0001735276-23-000079 · edgardoc.xml · nonDerivative · entry 6

Garg Pushkal · CIK 0001829252 · CMO & EVP Dev & Med Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,690

F3 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form.

F7 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $187.04 to $188.04. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
August 04, 2023 Filed Aug 7, 2023 22:05 UTC
Garg PushkalCMO & EVP Dev & Med Affairs
SaleCommon Stock 945 $186.39 $176,138.55
Disclosure

SEC source: 0001735276-23-000079 · edgardoc.xml · nonDerivative · entry 5

Garg Pushkal · CIK 0001829252 · CMO & EVP Dev & Med Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,776

F3 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form.

F6 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $186.03 to $187.02. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
August 04, 2023 Filed Aug 7, 2023 22:05 UTC
Garg PushkalCMO & EVP Dev & Med Affairs
SaleCommon Stock 1,593 $185.54 $295,565.22
Disclosure

SEC source: 0001735276-23-000079 · edgardoc.xml · nonDerivative · entry 4

Garg Pushkal · CIK 0001829252 · CMO & EVP Dev & Med Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,721

F3 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form.

F5 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $185.02 to $186.02. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
August 04, 2023 Filed Aug 7, 2023 22:05 UTC
Garg PushkalCMO & EVP Dev & Med Affairs
SaleCommon Stock 658 $184.70 $121,532.60
Disclosure

SEC source: 0001735276-23-000079 · edgardoc.xml · nonDerivative · entry 3

Garg Pushkal · CIK 0001829252 · CMO & EVP Dev & Med Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,314

F3 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form.

F4 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $184.01 to $185.01. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
August 04, 2023 Filed Aug 7, 2023 22:05 UTC
Poulton Jeffrey V.EVP, Chief Financial Officer
SaleCommon Stock 164 $189.31 $31,046.84
Disclosure

SEC source: 0001735276-23-000078 · edgardoc.xml · nonDerivative · entry 8

Poulton Jeffrey V. · CIK 0001782962 · EVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,873

F3 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form.

Read SEC document
August 04, 2023 Filed Aug 7, 2023 22:05 UTC
Poulton Jeffrey V.EVP, Chief Financial Officer
SaleCommon Stock 15 $188.40 $2,826.00
Disclosure

SEC source: 0001735276-23-000078 · edgardoc.xml · nonDerivative · entry 7

Poulton Jeffrey V. · CIK 0001782962 · EVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,037

F3 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form.

F8 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $188.14 to $189.05. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
August 04, 2023 Filed Aug 7, 2023 22:05 UTC
Poulton Jeffrey V.EVP, Chief Financial Officer
SaleCommon Stock 86 $187.37 $16,113.82
Disclosure

SEC source: 0001735276-23-000078 · edgardoc.xml · nonDerivative · entry 6

Poulton Jeffrey V. · CIK 0001782962 · EVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,052

F3 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form.

F7 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $187.04 to $188.04. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
August 04, 2023 Filed Aug 7, 2023 22:05 UTC
Poulton Jeffrey V.EVP, Chief Financial Officer
SaleCommon Stock 944 $186.39 $175,952.16
Disclosure

SEC source: 0001735276-23-000078 · edgardoc.xml · nonDerivative · entry 5

Poulton Jeffrey V. · CIK 0001782962 · EVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,138

F3 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form.

F6 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $186.03 to $187.02. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
August 04, 2023 Filed Aug 7, 2023 22:05 UTC
Poulton Jeffrey V.EVP, Chief Financial Officer
SaleCommon Stock 1,593 $185.54 $295,565.22
Disclosure

SEC source: 0001735276-23-000078 · edgardoc.xml · nonDerivative · entry 4

Poulton Jeffrey V. · CIK 0001782962 · EVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,082

F3 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form.

F5 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $185.02 to $186.02. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
August 04, 2023 Filed Aug 7, 2023 22:05 UTC
Poulton Jeffrey V.EVP, Chief Financial Officer
SaleCommon Stock 658 $184.70 $121,532.60
Disclosure

SEC source: 0001735276-23-000078 · edgardoc.xml · nonDerivative · entry 3

Poulton Jeffrey V. · CIK 0001782962 · EVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,675

F3 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form.

F4 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $184.01 to $185.01. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
August 04, 2023 Filed Aug 7, 2023 22:04 UTC
Greenstreet YvonneDirector · Chief Executive Officer
SaleCommon Stock 192 $189.31 $36,347.52
Disclosure

SEC source: 0001735276-23-000077 · edgardoc.xml · nonDerivative · entry 8

Greenstreet Yvonne · CIK 0001446125 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,216

F3 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form.

Read SEC document
August 04, 2023 Filed Aug 7, 2023 22:04 UTC
Greenstreet YvonneDirector · Chief Executive Officer
SaleCommon Stock 17 $188.40 $3,202.80
Disclosure

SEC source: 0001735276-23-000077 · edgardoc.xml · nonDerivative · entry 7

Greenstreet Yvonne · CIK 0001446125 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,408

F3 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form.

F8 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $188.14 to $189.05. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
August 04, 2023 Filed Aug 7, 2023 22:04 UTC
Greenstreet YvonneDirector · Chief Executive Officer
SaleCommon Stock 101 $187.37 $18,924.37
Disclosure

SEC source: 0001735276-23-000077 · edgardoc.xml · nonDerivative · entry 6

Greenstreet Yvonne · CIK 0001446125 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,425

F3 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form.

F7 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $187.04 to $188.04. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
August 04, 2023 Filed Aug 7, 2023 22:04 UTC
Greenstreet YvonneDirector · Chief Executive Officer
SaleCommon Stock 1,107 $186.39 $206,333.73
Disclosure

SEC source: 0001735276-23-000077 · edgardoc.xml · nonDerivative · entry 5

Greenstreet Yvonne · CIK 0001446125 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,526

F3 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form.

F6 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $186.03 to $187.02. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
August 04, 2023 Filed Aug 7, 2023 22:04 UTC
Greenstreet YvonneDirector · Chief Executive Officer
SaleCommon Stock 1,869 $185.54 $346,774.26
Disclosure

SEC source: 0001735276-23-000077 · edgardoc.xml · nonDerivative · entry 4

Greenstreet Yvonne · CIK 0001446125 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,633

F3 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form.

F5 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $185.02 to $186.02. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
August 04, 2023 Filed Aug 7, 2023 22:04 UTC
Greenstreet YvonneDirector · Chief Executive Officer
SaleCommon Stock 771 $184.70 $142,403.70
Disclosure

SEC source: 0001735276-23-000077 · edgardoc.xml · nonDerivative · entry 3

Greenstreet Yvonne · CIK 0001446125 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,502

F3 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form.

F4 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $184.01 to $185.01. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
August 04, 2023 Filed Aug 7, 2023 22:04 UTC SaleCommon Stock 192 $189.31 $36,347.52
Disclosure

SEC source: 0001735276-23-000076 · edgardoc.xml · nonDerivative · entry 8

Vaishnaw Akshay · CIK 0001458494 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,774

F3 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form.

Read SEC document
August 04, 2023 Filed Aug 7, 2023 22:04 UTC SaleCommon Stock 17 $188.40 $3,202.80
Disclosure

SEC source: 0001735276-23-000076 · edgardoc.xml · nonDerivative · entry 7

Vaishnaw Akshay · CIK 0001458494 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,966

F8 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting event.

F9 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $188.14 to $189.05. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
August 04, 2023 Filed Aug 7, 2023 22:04 UTC SaleCommon Stock 101 $187.37 $18,924.37
Disclosure

SEC source: 0001735276-23-000076 · edgardoc.xml · nonDerivative · entry 6

Vaishnaw Akshay · CIK 0001458494 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,983

F3 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form.

F7 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $187.04 to $188.04. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
August 04, 2023 Filed Aug 7, 2023 22:04 UTC SaleCommon Stock 1,107 $186.39 $206,333.73
Disclosure

SEC source: 0001735276-23-000076 · edgardoc.xml · nonDerivative · entry 5

Vaishnaw Akshay · CIK 0001458494 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,084

F3 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form.

F6 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $186.03 to $187.02. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
August 04, 2023 Filed Aug 7, 2023 22:04 UTC SaleCommon Stock 1,869 $185.54 $346,774.26
Disclosure

SEC source: 0001735276-23-000076 · edgardoc.xml · nonDerivative · entry 4

Vaishnaw Akshay · CIK 0001458494 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,191

F3 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form.

F5 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $185.02 to $186.02. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
August 04, 2023 Filed Aug 7, 2023 22:04 UTC SaleCommon Stock 771 $184.70 $142,403.70
Disclosure

SEC source: 0001735276-23-000076 · edgardoc.xml · nonDerivative · entry 3

Vaishnaw Akshay · CIK 0001458494 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,060

F3 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form.

F4 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $184.01 to $185.01. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
August 03, 2023 Filed Aug 4, 2023 20:02 UTC SaleCommon Stock 450 $187.71 $84,469.50
Disclosure

SEC source: 0001735276-23-000071 · edgardoc.xml · nonDerivative · entry 8

BONNEY MICHAEL W · CIK 0001219016 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,029

F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form.

F8 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $187.58 to $187.99. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
August 03, 2023 Filed Aug 4, 2023 20:02 UTC SaleCommon Stock 1,389 $187.04 $259,798.56
Disclosure

SEC source: 0001735276-23-000071 · edgardoc.xml · nonDerivative · entry 7

BONNEY MICHAEL W · CIK 0001219016 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,479

F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form.

F7 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $186.53 to $187.53. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
August 03, 2023 Filed Aug 4, 2023 20:02 UTC SaleCommon Stock 1,714 $185.99 $318,786.86
Disclosure

SEC source: 0001735276-23-000071 · edgardoc.xml · nonDerivative · entry 6

BONNEY MICHAEL W · CIK 0001219016 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,868

F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form.

F6 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $185.49 to $186.31. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
August 03, 2023 Filed Aug 4, 2023 20:02 UTC SaleCommon Stock 1,535 $184.89 $283,806.15
Disclosure

SEC source: 0001735276-23-000071 · edgardoc.xml · nonDerivative · entry 5

BONNEY MICHAEL W · CIK 0001219016 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,582

F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form.

F5 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $184.48 to $185.44. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
August 03, 2023 Filed Aug 4, 2023 20:02 UTC SaleCommon Stock 560 $183.75 $102,900.00
Disclosure

SEC source: 0001735276-23-000071 · edgardoc.xml · nonDerivative · entry 4

BONNEY MICHAEL W · CIK 0001219016 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,117

F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form.

F4 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $183.20 to $184.15. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
August 03, 2023 Filed Aug 4, 2023 20:02 UTC SaleCommon Stock 500 $182.45 $91,225.00
Disclosure

SEC source: 0001735276-23-000071 · edgardoc.xml · nonDerivative · entry 3

BONNEY MICHAEL W · CIK 0001219016 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,677

F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form.

F3 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $182.13 to $183.06. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
August 03, 2023 Filed Aug 4, 2023 20:02 UTC SaleCommon Stock 300 $181.08 $54,324.00
Disclosure

SEC source: 0001735276-23-000071 · edgardoc.xml · nonDerivative · entry 2

BONNEY MICHAEL W · CIK 0001219016 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,177

F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form.

F2 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $181.00 to $181.25. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
August 03, 2023 Filed Aug 7, 2023 22:05 UTC
Garg PushkalCMO & EVP Dev & Med Affairs
GrantCommon Stock 3,109 $0.00 $0.00
Disclosure

SEC source: 0001735276-23-000079 · edgardoc.xml · nonDerivative · entry 2

Garg Pushkal · CIK 0001829252 · CMO & EVP Dev & Med Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,972

F2 · kind: On February 24, 2021, the reporting person was granted performance-based stock units (PSUs) in connection with the issuer 2020 year-end compensation review. The PSUs vest in separate installments based on the achievement of four specified performance measures as determined by the People, Culture and Compensation Committee of the issuer Board of Directors. The shares reported were issued to the reporting person upon vesting of one-quarter of the PSUs based on achievement of a corresponding performance measure relating to the issuer public reporting of the achievement of the first $2.5 billion in cumulative net product revenues determined in accordance with GAAP based solely upon the sales by the Company, including its affiliates and ex-U.S. distributions, of products discovered/developed by the Company.

Read SEC document
August 03, 2023 Filed Aug 7, 2023 22:05 UTC
Garg PushkalCMO & EVP Dev & Med Affairs
GrantCommon Stock 4,518 $0.00 $0.00
Disclosure

SEC source: 0001735276-23-000079 · edgardoc.xml · nonDerivative · entry 1

Garg Pushkal · CIK 0001829252 · CMO & EVP Dev & Med Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,863

F1 · kind: On February 26, 2020, the reporting person was granted performance-based stock units (PSUs) in connection with the issuer 2019 year-end compensation review. The PSUs vest in separate installments based on the achievement of three specified performance measures as determined by the People, Culture and Compensation Committee of the issuer Board of Directors. The shares reported were issued to the reporting person upon vesting of one-third of the PSUs based on achievement of a corresponding performance measure relating to the issuer public reporting of the achievement of the first $2.5 billion in cumulative net product revenues determined in accordance with GAAP based solely upon the sales by the Company, including its affiliates and ex-U.S. distributions, of products discovered/developed by the Company.

Read SEC document
August 03, 2023 Filed Aug 7, 2023 22:05 UTC
Poulton Jeffrey V.EVP, Chief Financial Officer
GrantCommon Stock 3,109 $0.00 $0.00
Disclosure

SEC source: 0001735276-23-000078 · edgardoc.xml · nonDerivative · entry 2

Poulton Jeffrey V. · CIK 0001782962 · EVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,333

F2 · kind: On February 24, 2021, the reporting person was granted performance-based stock units (PSUs) in connection with the issuer 2020 year-end compensation review. The PSUs vest in separate installments based on the achievement of four specified performance measures as determined by the People, Culture and Compensation Committee of the issuer Board of Directors. The shares reported were issued to the reporting person upon vesting of one-quarter of the PSUs based on achievement of a corresponding performance measure relating to the issuer public reporting of the achievement of the first $2.5 billion in cumulative net product revenues determined in accordance with GAAP based solely upon the sales by the Company, including its affiliates and ex-U.S. distributions, of products discovered/developed by the Company.

Read SEC document
August 03, 2023 Filed Aug 7, 2023 22:05 UTC
Poulton Jeffrey V.EVP, Chief Financial Officer
GrantCommon Stock 4,518 $0.00 $0.00
Disclosure

SEC source: 0001735276-23-000078 · edgardoc.xml · nonDerivative · entry 1

Poulton Jeffrey V. · CIK 0001782962 · EVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,224

F1 · kind: On February 26, 2020, the reporting person was granted performance-based stock units (PSUs) in connection with the issuer 2019 year-end compensation review. The PSUs vest in separate installments based on the achievement of three specified performance measures as determined by the People, Culture and Compensation Committee of the issuer Board of Directors. The shares reported were issued to the reporting person upon vesting of one-third of the PSUs based on achievement of a corresponding performance measure relating to the issuer public reporting of the achievement of the first $2.5 billion in cumulative net product revenues determined in accordance with GAAP based solely upon the sales by the Company, including its affiliates and ex-U.S. distributions, of products discovered/developed by the Company.

Read SEC document
August 03, 2023 Filed Aug 7, 2023 22:04 UTC
Greenstreet YvonneDirector · Chief Executive Officer
GrantCommon Stock 3,859 $0.00 $0.00
Disclosure

SEC source: 0001735276-23-000077 · edgardoc.xml · nonDerivative · entry 2

Greenstreet Yvonne · CIK 0001446125 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,273

F2 · kind: On February 24, 2021, the reporting person was granted performance-based stock units (PSUs) in connection with the issuer 2020 year-end compensation review. The PSUs vest in separate installments based on the achievement of four specified performance measures as determined by the People, Culture and Compensation Committee of the issuer Board of Directors. The shares reported were issued to the reporting person upon vesting of one-quarter of the PSUs based on achievement of a corresponding performance measure relating to the issuer public reporting of the achievement of the first $2.5 billion in cumulative net product revenues determined in accordance with GAAP based solely upon the sales by the Company, including its affiliates and ex-U.S. distributions, of products discovered/developed by the Company.

Read SEC document
August 03, 2023 Filed Aug 7, 2023 22:04 UTC
Greenstreet YvonneDirector · Chief Executive Officer
GrantCommon Stock 5,082 $0.00 $0.00
Disclosure

SEC source: 0001735276-23-000077 · edgardoc.xml · nonDerivative · entry 1

Greenstreet Yvonne · CIK 0001446125 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,414

F1 · kind: On February 26, 2020, the reporting person was granted performance-based stock units (PSUs) in connection with the issuer 2019 year-end compensation review. The PSUs vest in separate installments based on the achievement of three specified performance measures as determined by the People, Culture and Compensation Committee of the issuer Board of Directors. The shares reported were issued to the reporting person upon vesting of one-third of the PSUs based on achievement of a corresponding performance measure relating to the issuer public reporting of the achievement of the first $2.5 billion in cumulative net product revenues determined in accordance with GAAP based solely upon the sales by the Company, including its affiliates and ex-U.S. distributions, of products discovered/developed by the Company.

Read SEC document
August 03, 2023 Filed Aug 7, 2023 22:04 UTC GrantCommon Stock 3,859 $0.00 $0.00
Disclosure

SEC source: 0001735276-23-000076 · edgardoc.xml · nonDerivative · entry 2

Vaishnaw Akshay · CIK 0001458494 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,831

F2 · kind: On February 24, 2021, the reporting person was granted performance-based stock units (PSUs) in connection with the issuer 2020 year-end compensation review. The PSUs vest in separate installments based on the achievement of four specified performance measures as determined by the People, Culture and Compensation Committee of the issuer Board of Directors. The shares reported were issued to the reporting person upon vesting of one-quarter of the PSUs based on achievement of a corresponding performance measure relating to the issuer public reporting of the achievement of the first $2.5 billion in cumulative net product revenues determined in accordance with GAAP based solely upon the sales by the Company, including its affiliates and ex-U.S. distributions, of products discovered/developed by the Company.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.